Page last updated: 2024-10-19

phosphoenolpyruvate and Pancreatic Neoplasms

phosphoenolpyruvate has been researched along with Pancreatic Neoplasms in 1 studies

Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sjöholm, A1
Lehtihet, M1
Efanov, AM1
Zaitsev, SV1
Berggren, PO1
Honkanen, RE1

Other Studies

1 other study available for phosphoenolpyruvate and Pancreatic Neoplasms

ArticleYear
Glucose metabolites inhibit protein phosphatases and directly promote insulin exocytosis in pancreatic beta-cells.
    Endocrinology, 2002, Volume: 143, Issue:12

    Topics: Animals; Calcium; Citric Acid; Drug Synergism; Enzyme Inhibitors; Exocytosis; Fructosediphosphates;

2002